{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:19:28Z","timestamp":1780647568646,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["PI21\/00165"],"award-info":[{"award-number":["PI21\/00165"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Otorrinolaringologica (English Edition)"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.otoeng.2024.04.001","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T12:40:32Z","timestamp":1715172032000},"page":"288-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Upper airway manifestations of anti-IgLON5 disease: Otorhinolaryngological point of view"],"prefix":"10.1016","volume":"75","author":[{"given":"Daniela","family":"Pastene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Jubes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Iranzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Gaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Vilaseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.otoeng.2024.04.001_bib0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterization of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of antiIgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.29245\/2572.942X\/2020\/3.1269","article-title":"Anti-Iglon5 syndrome: What we know so far? A non-systematic review","volume":"5","author":"da Silva","year":"2020","journal-title":"J Neurol Neuromed"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0020","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0025","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0030","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1074\/jbc.M114.628438","article-title":"IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth","volume":"290","author":"Sanz","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ana.25857","article-title":"Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration","volume":"885","author":"Landa","year":"2020","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.otoeng.2024.04.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0045","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0050","doi-asserted-by":"crossref","first-page":"E724","DOI":"10.1002\/lary.28911","article-title":"A novel presentation of the acute airway: anti-IgLON5 disease","volume":"131","author":"Chen","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0055","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1212\/NXI.0000000000000302","article-title":"Isolated dysphagia as initial sign of anti-IgLON5 syndrome","volume":"4","author":"Schr\u00f6der","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0060","doi-asserted-by":"crossref","first-page":"rjad140","DOI":"10.1093\/jscr\/rjad140","article-title":"Thinking beyond otorhinolaryngology in patients presenting with bilateral vocal cord paresis","volume":"30","author":"Usman","year":"2023","journal-title":"J Surg Case Rep"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0110","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz133","article-title":"Characterization of the sleep disorder of Anti-IgLON5 disease","volume":"42","author":"Gaig","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa191","article-title":"Stridor during sleep: description of 81 consecutive cases diagnosed in a tertiary sleep disorders center","volume":"44","author":"Silva","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.800298","article-title":"Epileptic seizures and right-sided hippocampal swelling as presenting symptoms of anti-IgLON5 disease: a case report and systematic review of the literature","volume":"13","author":"Fu","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0070","doi-asserted-by":"crossref","first-page":"e962","DOI":"10.1212\/NXI.0000000000000962","article-title":"Anti-IgLON5 disease: a new bulbar-onset motor neuron mimic syndrome","volume":"8","author":"Werner","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11910-018-0848-0","article-title":"The sleep disorder in anti-Lglon5 disease","volume":"18","author":"Gaig","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cns.13038","article-title":"Motor neuron disease\u2010like phenotype associated with anti\u2010IgLON5 disease","volume":"24","author":"Tao","year":"2018","journal-title":"CNS Neurosci Therap"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.anl.2007.03.006","article-title":"Paradoxical vocal cord motion: a review focused on multiple system atrophy","volume":"34","author":"Shiba","year":"2007","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0090","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-201105","article-title":"Hypothalamic-bulbar MRI hyperintensity in anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature","volume":"79","author":"Tagliapietra","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0100","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/hn.1999.v120.a93228","article-title":"Current evaluation and treatment of patients with swallowing disorders","volume":"120","author":"Broniatowski","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otoeng.2024.04.001_bib0105","article-title":"Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis","volume":"5","author":"James","year":"2022","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Acta Otorrinolaringologica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573524000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573524000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:43:14Z","timestamp":1760643794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173573524000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2173573524000516"],"URL":"https:\/\/doi.org\/10.1016\/j.otoeng.2024.04.001","relation":{},"ISSN":["2173-5735"],"issn-type":[{"value":"2173-5735","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upper airway manifestations of anti-IgLON5 disease: Otorhinolaryngological point of view","name":"articletitle","label":"Article Title"},{"value":"Acta Otorrinolaringologica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otoeng.2024.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Otorrinolaringolog\u00eda y Cirug\u00eda de Cabeza y Cuello. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}